These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1655262)

  • 1. Duration of angiotensin-converting enzyme inhibition: implications for tolerability.
    Murray NH
    Cardiology; 1991; 79 Suppl 1():22-9. PubMed ID: 1655262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD; Katz R; Sullivan JM; Wolfson P; Haugland M; Kirlin P; Powers E; Rich S; Hackshaw B; Chiaramida A
    J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of lisinopril in older hypertensive patients.
    Rush JE; Lyle PA
    Am J Med; 1988 Sep; 85(3B):55-9. PubMed ID: 2844089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with lisinopril. Observations on safety and tolerability.
    Cameron HA; Higgins TJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():177-86. PubMed ID: 2550641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study.
    Rappelli A
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():55-7; discussion 57-8. PubMed ID: 1665178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lisinopril in older patients with essential hypertension.
    Gomez HJ; Smith SG; Moncloa F
    Am J Med; 1988 Sep; 85(3B):35-7. PubMed ID: 2844085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating mild-to-moderate hypertension: a comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination.
    Graham RD
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():59-60; discussion 61. PubMed ID: 1665179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
    Powers ER; Chiaramida A; DeMaria AN; Giles TD; Hackshaw B; Hart W; Haugland M; Johnston R; Katz R; Kirlin P
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S82-8. PubMed ID: 2442559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ; Gomez HJ; Salonen J; Salonen R; Rissanen V; Bolognese JA; Nyberg R; Kristianson K
    Br J Clin Pharmacol; 1988 May; 25(5):533-8. PubMed ID: 2841960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ; Meany TB; Johnston GD; Kondowe G; Grimmer SF; Breckenridge AM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA; Murray KM
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S; Serradimigni A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.
    Mörlin C; Baglivo H; Boeijinga JK; Breckenridge AM; Clement D; Johnston GD; Klein W; Kramer R; Luccioni R; Meurer KA
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S49-52. PubMed ID: 2442552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitors and cough.
    Yeşil S; Yeşil M; Bayata S; Postaci N
    Angiology; 1994 Sep; 45(9):805-8. PubMed ID: 8092546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.